Synthetic Biologics, Inc. Uncategorized Contracts & Agreements
37 Contracts & Agreements
- Description of Securities of Theriva Biologics, Inc (Filed With SEC on March 25, 2024)
- Description of Securities of Theriva Biologics, Inc (Filed With SEC on March 30, 2023)
- Technology Transfer Agreement between Bellvitge Biomedical Research Institute and VCN Biosciences S.L. dated August 31, 2010 (Filed With SEC on March 16, 2022)
- Description of Securities of Synthetic Biologics, Inc (Filed With SEC on March 16, 2022)
- DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (Filed With SEC on March 4, 2021)
- Description of Securities (Filed With SEC on February 20, 2020)
- Clinical Trial Agreement between Washington University School of Medicine in St. Louis and Synthetic Biologics, Inc. dated August 7, 2019 (Filed With SEC on August 8, 2019)
- Fifth Amendment dated August 22, 2017 to Sponsored Research Agreement dated December 19, 2012 between Synthetic Biologics, Inc. and The University of Texas at Austin (Filed With SEC on February 22, 2018)
- Exhibit B (Filed With SEC on November 15, 2016)
- Exhibit A (Filed With SEC on November 15, 2016)
- FORM OF STOCKOPTION GRANT NOTICE (Filed With SEC on December 10, 2015)
- THIRD AMENDMENT TO EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on November 5, 2015)
- SECOND AMENDMENT TO REGISTRATION RIGHTSAGREEMENT (Filed With SEC on August 10, 2015)
- AMENDMENT TO CLINICAL TRIAL AGREEMENT (Filed With SEC on July 9, 2015)
- CLINICAL TRIAL AGREEMENT (Filed With SEC on July 9, 2015)
- STOCKPURCHASE AGREEMENT (Filed With SEC on December 10, 2013)
- STOCKPURCHASE AGREEMENT (Filed With SEC on December 10, 2013)
- EXCLUSIVE OPTION AGREEMENT (Filed With SEC on December 10, 2013)
- FOURTH AMENDMENT TO EXCLUSIVE LICENSEAGREEMENT UC Agreement Control No. 2006-04-0026 (Filed With SEC on April 16, 2013)
- THIRD AMENDMENT TO EXCLUSIVE LICENSEAGREEMENT UC Agreement Control No. 2006-04-0026 (Filed With SEC on April 16, 2013)
- First Amendment to theLicense Agreement Between The Regents of the University of California and General Fiber, Inc. UC Agreement Control No. 2006-04-0026 (Filed With SEC on April 16, 2013)
- SPONSORED RESEARCH AGREEMENT NO. UTA12-000950 (Filed With SEC on December 21, 2012)
- PATENT LICENSEAGREEMENT AGT. No.PM1300101 (Filed With SEC on December 21, 2012)
- FIRST AMENDMENT TO REGISTRATION RIGHTSAGREEMENT (Filed With SEC on August 9, 2012)
- EXECUTIONVERSION SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 2, 2011)
- Very truly yours, Adeona Pharmaceuticals, Inc. By: Name:James S. Kuo, M.D., M.B.A. Title:Chairman and CEO Chardan Capital Markets, LLC By: Name: Title: (Filed With SEC on February 2, 2011)
- [Signature Page Follows] (Filed With SEC on July 6, 2010)
- Re:License agreement between Pipex Therapeutics, Inc. and Meda AB (Filed With SEC on May 11, 2010)
- SUBLICENSE AGREEMENT BETWEEN MEDA AB AND PIPEX THERAPEUTICS, INC. May 6, 2010 (Filed With SEC on May 11, 2010)
- Consent in Lieu of Special Meeting of the Board of Directors of Adeona Pharmaceuticals, Inc. (Filed With SEC on August 26, 2009)
- SECOND AMENDMENT TO (Filed With SEC on July 16, 2009)
- AMENDMENT (Filed With SEC on July 16, 2009)
- EMPLOYMENTAGREEMENT (Filed With SEC on July 2, 2009)
- Exhibit10.1 STOCKPURCHASE AGREEMENT (Filed With SEC on April 16, 2009)
- AGREEMENTBY AND BETWEEN ACCREDITEDVENTURE CAPITAL, LLC AND ADEONAPHARMACEUTICALS, INC. DATEDJANUARY 14, 2009 (Filed With SEC on January 20, 2009)
- Departure of directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on January 6, 2009)
- Departure of directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (Filed With SEC on January 6, 2009)
